Emergent Health Corp
EMGE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.01 | -0.04 | -3.13 |
| FCF Yield | -432.43% | -186.51% | -4.97% | -1.39% |
| EV / EBITDA | -1.97 | -1.56 | -18.56 | -70.70 |
| Quality | ||||
| ROIC | -1,079.22% | -291.45% | -54.04% | -24.80% |
| Gross Margin | 63.49% | 22.21% | 49.74% | 72.62% |
| Cash Conversion Ratio | 0.75 | 0.90 | 0.56 | 0.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 139.13% | 50.91% | -13.25% | -44.72% |
| Free Cash Flow Growth | 37.32% | -1,104.05% | -182.31% | -5.55% |
| Safety | ||||
| Net Debt / EBITDA | -1.77 | -0.95 | -0.44 | 3.03 |
| Interest Coverage | -6.40 | -4.86 | -2.21 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -153.83 | 8.94 | -58.19 | 0.00 |